Acquiring Company
ClearPoint Neuro
Acquired Company
IRRAS Holdings
Solana BeachDelawareBiotechnologyHealthcareHealth CareTherapeuticsManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
ClearPoint Neuro has successfully acquired IRRAS Holdings for $5 million in cash and additional shares. This acquisition will enhance ClearPoint's capabilities in CNS drug delivery and expand its operational scale. The addition of IRRAS's technology and customers is expected to significantly benefit ClearPoint's portfolio in neurocritical care.
Quick answer
ClearPoint Neuro is acquiring IRRAS Holdings for $5 million, announced November 20, 2025. ClearPoint Neuro is based in Solana Beach, California, United States.
- How much did ClearPoint Neuro pay for IRRAS Holdings?
- The reported deal value is $5 million.
- What does ClearPoint Neuro do?
- ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine.
- Where are ClearPoint Neuro and IRRAS Holdings based?
- ClearPoint Neuro is based in Solana Beach, California, United States. IRRAS Holdings is based in Delaware, United States.
- Who are the decision-makers at ClearPoint Neuro?
- Fundz holds 1 contact at ClearPoint Neuro. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Galecto, Inc. Acquires Damora Therapeutics, Inc. (November 10, 2025)
- BioMarin to acquire Amicus for $4.8 billion, $4.8B (December 19, 2025)
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- OSR Holdings to acquire Woori IO for diabetes care (October 14, 2025)
- Pfizer completes $43 billion acquisition of Seagen, $43B (January 4, 2026)
- Azenta, Inc. Completes Acquisition of B Medical Systems (December 23, 2025)
Who to call at ClearPoint Neuro, and when
When ClearPoint Neuro changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ClearPoint Neuro raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ClearPoint Neuro, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ClearPoint Neuro. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ClearPoint Neuro makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired IRRAS Holdings?
IRRAS Holdings was acquired by ClearPoint Neuro, based in Solana Beach. The deal was reported on November 20, 2025. ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. ClearPoint Neuro is publicly traded (CLPT) and operates in Biotechnology.
When did ClearPoint Neuro acquire IRRAS Holdings?
ClearPoint Neuro's acquisition of IRRAS Holdings was reported on November 20, 2025. ClearPoint Neuro has successfully acquired IRRAS Holdings for $5 million in cash and additional shares. This acquisition will enhance ClearPoint's capabilities in CNS drug delivery and expand its operational scale. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does IRRAS Holdings do?
IRRAS Holdings, Inc. is a medical technology company that develops and commercializes innovative therapeutic solutions for various neurological conditions. The company is known for its cutting-edge products aimed at improving patient outcomes in neurosurgery. It is privately held, operating in Manufacturing, and is based in Delaware.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.